BUCOLO, CLAUDIO

BUCOLO, CLAUDIO  

SCIENZE BIOMEDICHE E BIOTECNOLOGICHE  

Risultati 1 - 20 di 304 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autore(i) File
A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptors 1-gen-2006 Bucolo, Claudio; Marrazzo, Agostino; Ronsisvalle, Simone; Ronsisvalle, Giuseppe; Cuzzocrea, S; Mazzon, E; Caputi, A; Drago, Filippo
A prolonged release polymeric nanocarrier for ocular administration 1-gen-2009 Musumeci, Teresa; Pignatello, Rosario; Bucolo, Claudio; Puglisi, Giovanni
A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits 1-gen-2009 Stagni, E; Privitera, Mg; Bucolo, Claudio; Leggio, GIAN MARCO; Motterlini, R; Drago, Filippo
Acidic Mammalian chitinase and the eye: implications for ocular inflammatory diseases. 1-gen-2011 Bucolo, Claudio; Musumeci, M; Musumeci, S; Drago, Filippo
Acidic mammalian chitinase in dry eye conditions 1-gen-2009 Musumeci, M; Aragona, P; Bellin, M; Maugeri, F; Rania, L; Bucolo, Claudio; Musumeci, S.
L'acido Ialuronico come Carrier Ideale nella Veicolazione Topica Oculare del Timololo 1-gen-1994 Spadaro, Angelo; Bucolo, Claudio; Cro, M; Giuffrida, A; Maltese, A.
The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome 1-gen-2019 Trotta, Maria Consiglia; Maisto, Rosa; Guida, Francesca; Boccella, Serena; Luongo, Livio; Balta, Cornel; D’Amico, Giovanbattista; Herman, Hildegard; Hermenean, Anca; Bucolo, Claudio; D’Amico, Michele
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 1-gen-2020 Giurdanella, G.; Lupo, G.; Gennuso, F.; Conti, F.; Lo Furno, D.; Mannino, G.; Anfuso, C. D.; Drago, F.; Salomone, S.; Bucolo, C.
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 1-gen-2022 Maugeri, Grazia; D’Amico, Agata Grazia; Giunta, Salvatore; Giallongo, Cesarina; Tibullo, Daniele; Bucolo, Claudio; Saccone, Salvatore; Federico, Concetta; Scollo, Davide; Longo, Antonio; Avitabile, Teresio; Musumeci, Giuseppe; D’Agata, Velia
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 1-gen-2019 Lazzara, F.; Fidilio, A.; Platania, C. B. M.; Giurdanella, G.; Salomone, S.; Leggio, G. M.; Tarallo, V.; Cicatiello, V.; De Falco, S.; Eandi, C. M.; Drago, F.; Bucolo, C.
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 1-gen-2015 Giurdanella, G; Anfuso, CARMELINA DANIELA; Olivieri, M; Lupo, Gabriella; Caporarello, N; Eandi, Cm; Drago, Filippo; Bucolo, Claudio; Salomone, Salvatore
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 1-gen-2020 Stark, Tibor; Di Bartolomeo, Martina; Di Marco, Roberta; Drazanova, Eva; Platania, Chiara Bianca Maria; Iannotti, Fabio Arturo; Ruda-Kucerova, Jana; D'Addario, Claudio; Kratka, Lucie; Pekarik, Vladimir; Piscitelli, Fabiana; Babinska, Zuzana; Fedotova, Julia; Giurdanella, Giovanni; Salomone, Salvatore; Sulcova, Alexandra; Bucolo, Claudio; Wotjak, Carsten T; Starcuk, Zenon; Drago, Filippo; Mechoulam, Raphael; Di Marzo, Vincenzo; Micale, Vincenzo
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 1-gen-2015 Giurdanella, G.; Anfuso, CARMELINA DANIELA; Olivieri, M.; Lupo, Gabriella; Caporarello, N.; Eandi, C. M.; Drago, Filippo; Bucolo, Claudio; Salomone, Salvatore
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 1-gen-2016 Leggio, GIAN MARCO; Catania, Mv; Puzzo, Daniela; Spatuzza, M; Pellitteri, R; Gulisano, W; Torrisi, Sa; Giurdanella, G; Piazza, C; Impellizzeri, Ar; Gozzo, L; Navarria, A; Bucolo, Claudio; Nicoletti, F; Palmeri, Agostino; Salomone, Salvatore; Copani, Agata Graziella; Caraci, F; Drago, Filippo
Antioxidant and osmoprotecting activity of taurine in dry eye models 1-gen-2018 Bucolo, Claudio; Fidilio, A; Platania, Cbm; Geraci, F; Lazzara, F; Drago, Filippo
Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries 1-gen-2017 Villari, Ambra; Giurdanella, Giovanni; Bucolo, Claudio; Drago, Filippo; Salomone, Salvatore
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 1-gen-2021 Santonocito, M.; Zappulla, C.; Viola, S.; Rosa, L. R. L.; Solfato, E.; Abbate, I.; Tarallo, V.; Apicella, I.; Platania, C. B. M.; Maugeri, G.; D'Agata, V.; Bucolo, C.; De Falco, S.; Mazzone, M. G.; Giuliano, F.
Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway Inhibition 1-gen-2021 Maugeri, G.; Bucolo, C.; Drago, F.; Rossi, S.; Di Rosa, M.; Imbesi, R.; D'Agata, V.; Giunta, S.
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant. 1-gen-2013 Tamburella, A; Leggio, GIAN MARCO; Micale, Vincenzo; Navarria, A; Bucolo, Claudio; Cicirata, V; Drago, Filippo; Salomone, Salvatore
Biocompatibility and biodegradation of intravitreal hyluronan implants in rabbits 1-gen-2001 Avitabile, Teresio; Marano, F; Castiglione, F; Bucolo, Claudio; Cro, M; Ambrosio, L; Ferrato, C; Reibaldi, A.